Latest Insider Transactions at Molina Healthcare, Inc. (MOH)
This section provides a real-time view of insider transactions for Molina Healthcare, Inc. (MOH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MOLINA HEALTHCARE, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MOLINA HEALTHCARE, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 22
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-3.61%
|
$9,930,000
$331.39 P/Share
|
|
Sep 22
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Sep 21
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
27,276
-1.12%
|
$9,164,736
$336.18 P/Share
|
|
Sep 21
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,876
+8.97%
|
$1,867,692
$67.33 P/Share
|
|
Sep 20
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-1.56%
|
$10,170,000
$339.28 P/Share
|
|
Sep 20
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Sep 19
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,600
-1.12%
|
$10,373,400
$339.73 P/Share
|
|
Sep 19
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Sep 15
2022
|
Richard M Schapiro Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
300
-1.98%
|
$103,200
$344.19 P/Share
|
|
Sep 09
2022
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
150
-0.9%
|
$53,100
$354.29 P/Share
|
|
Sep 08
2022
|
Jeff D. Barlow Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
14,480
-17.96%
|
$5,068,000
$350.0 P/Share
|
|
Sep 08
2022
|
Daniel Cooperman Director |
SELL
Open market or private sale
|
Direct |
2,500
-35.16%
|
$882,500
$353.0 P/Share
|
|
Sep 08
2022
|
Daniel Cooperman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+26.01%
|
$82,500
$33.02 P/Share
|
|
Sep 07
2022
|
Daniel Cooperman Director |
SELL
Open market or private sale
|
Direct |
2,500
-35.16%
|
$865,000
$346.0 P/Share
|
|
Sep 07
2022
|
Daniel Cooperman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+26.01%
|
$82,500
$33.02 P/Share
|
|
Aug 26
2022
|
Steven J Orlando Director |
SELL
Open market or private sale
|
Indirect |
500
-2.41%
|
$177,500
$355.4 P/Share
|
|
Aug 12
2022
|
Jeff D. Barlow Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
536
-0.66%
|
$178,488
$333.02 P/Share
|
|
Aug 09
2022
|
Mark Lowell Keim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,000
-13.66%
|
$3,960,000
$330.24 P/Share
|
|
Aug 09
2022
|
Jeff D. Barlow Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
90
-0.11%
|
$29,970
$333.01 P/Share
|
|
Aug 08
2022
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
200
-1.19%
|
$65,400
$327.04 P/Share
|
|
Aug 03
2022
|
James Woys Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
25,000
-39.8%
|
$8,200,000
$328.11 P/Share
|
|
Aug 02
2022
|
Dale B Wolf Director |
SELL
Open market or private sale
|
Direct |
2,000
-14.47%
|
$654,000
$327.99 P/Share
|
|
Aug 02
2022
|
Dale B Wolf Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+12.64%
|
$66,000
$33.02 P/Share
|
|
Jul 01
2022
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
194
+1.14%
|
$54,708
$282.9 P/Share
|
|
Jul 01
2022
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+4.62%
|
$54,708
$282.9 P/Share
|
|
Jul 01
2022
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+1.26%
|
$54,708
$282.9 P/Share
|
|
Jul 01
2022
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
194
+0.93%
|
$54,708
$282.9 P/Share
|
|
Jul 01
2022
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+1.61%
|
$54,708
$282.9 P/Share
|
|
Jul 01
2022
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+15.29%
|
$54,708
$282.9 P/Share
|
|
Jul 01
2022
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
194
+3.54%
|
$54,708
$282.9 P/Share
|
|
Jul 01
2022
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+4.04%
|
$54,708
$282.9 P/Share
|
|
Jun 30
2022
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78
+0.12%
|
$21,762
$279.61 P/Share
|
|
Jun 30
2022
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78
+0.1%
|
$21,762
$279.61 P/Share
|
|
Jun 07
2022
|
Dale B Wolf Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+14.67%
|
$66,000
$33.02 P/Share
|
|
May 06
2022
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
200
-1.19%
|
$61,400
$307.94 P/Share
|
|
Apr 01
2022
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
162
+4.07%
|
$54,918
$339.41 P/Share
|
|
Apr 01
2022
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
162
+0.78%
|
$54,918
$339.41 P/Share
|
|
Apr 01
2022
|
Marc Russo EVP, Health Plans |
SELL
Payment of exercise price or tax liability
|
Direct |
2,179
-11.35%
|
$738,681
$339.41 P/Share
|
|
Apr 01
2022
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
162
+3.09%
|
$54,918
$339.41 P/Share
|
|
Apr 01
2022
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
162
+1.65%
|
$54,918
$339.41 P/Share
|
|
Apr 01
2022
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
162
+1.07%
|
$54,918
$339.41 P/Share
|
|
Apr 01
2022
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
162
+0.95%
|
$54,918
$339.41 P/Share
|
|
Apr 01
2022
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
162
+3.54%
|
$54,918
$339.41 P/Share
|
|
Apr 01
2022
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
162
+15.53%
|
$54,918
$339.41 P/Share
|
|
Mar 15
2022
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
200
-1.18%
|
$62,800
$314.36 P/Share
|
|
Mar 08
2022
|
Steven J Orlando Director |
SELL
Open market or private sale
|
Indirect |
591
-2.81%
|
$183,801
$311.0 P/Share
|
|
Mar 07
2022
|
Joseph M Zubretsky President & CEO |
SELL
Bona fide gift
|
Direct |
1,600
-0.62%
|
-
|
|
Mar 04
2022
|
Jeff D. Barlow Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.8%
|
$1,575,000
$315.0 P/Share
|
|
Mar 01
2022
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,205
-10.45%
|
$3,173,755
$311.88 P/Share
|
|
Mar 01
2022
|
Mark Lowell Keim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,152
+17.56%
|
$6,889,272
$311.88 P/Share
|